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 Abstract 
  Background/Aim:   Fas ligand (FasL) and tumor necrosis factor (TNF)-     are major pro-apoptotic 
molecules and also induce inflammation through cytokine and chemokine production. Al-
though precise intracellular mechanisms of action have been reported for each molecule, the 
differential impact of these molecules on kidney injury in vivo still requires clarification.   Meth-
ods:   We explored the differential impact of FasL and TNF-     upon apoptosis and inflammation 
in ischemic acute kidney injury using neutralizing anti-FasL antibodies and TNF-     receptor 1 
(TNFR1)-deficient mice.   Results:   TNFR1 deficiency was associated with a lesser anti-inflamma-
tory effect upon leukocyte infiltration and tubular necrosis than treatment with anti-FasL anti-
body. Furthermore, the number of TUNEL-positive cells was significantly reduced in anti-FasL 
antibody-treated mice, whereas it was only partially diminished in TNFR1-deficient mice. In vitro 
studies confirmed these findings. FasL administration induced both apoptosis and cytokine/
chemokine production from cultured tubular epithelial cells. However, TNF-     had a limited ef-
fect upon tubular epithelial cells.   Conclusion:   In ischemic acute kidney injury, FasL has a great-
er impact than TNF-     on the apoptosis and inflammatory reaction through cytokine/chemo-
kine production from tubular epithelial cells.    Copyright © 2012 S. Karger AG, Basel 
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EXTRA
 Kengo  Furuichi 
This is an Open Access article licensed under the terms of the Creative Commons Attribution- 
NonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online 
version of the article only. Distribution for non-commercial purposes only.
  Division of Blood Purification 
  Kanazawa University Hospital 
  13-1 Takara-machi, Kanazawa 920-8641 (Japan) 
  Tel. +81 76 265 2030, E-Mail kfuruichi    @   m-kanazawa.jp 
www.karger.com/nne
 DOI:  10.1159/000335533 28
Nephron Extra 2012;2:27–38
 DOI:  10.1159/000335533 
EXTRA
  Furuichi et al.: FasL and TNF-     in Ischemic Acute Kidney Injury 
www.karger.com/nne
    © 2012 S. Karger AG, Basel
  Published online: February 3, 2012 
 Introduction 
 Programmed cell death was originally thought to occur in the absence of inflammation, 
and was observed in both development and normal cell turnover. In contrast to apoptosis, 
unscheduled cell death was thought to induce inflammation with necrosis observed in sys-
temic or local acute injury. However, several studies have indicated that apoptosis is a bio-
logical consequence of acute injury and may contribute to the inflammatory response   [1–4]  . 
Consistent with these suggestions, the inhibition of apoptosis may protect tissue against in-
flammatory damage   [4–6]  .
    Fas ligand (FasL) and tumor necrosis factor (TNF)-     are two key pro-apoptotic mole-
cules and are expressed by inflammatory cells as well as by resident cells. These molecules 
may also induce inflammation through the production of various cytokines and chemokines 
  [2, 7–9]  . Several previous reports indicated that FasL/Fas is involved in the pathogenesis of 
acute ischemic kidney injury via tubular apoptosis and necrosis   [11, 12]  . Indirect evidence 
has also reported a role of TNF-     in acute ischemic kidney injury   [13, 14]  . However, the dif-
ferential impact of these two molecules on apoptosis and inflammation in ischemic kidney 
injury in vivo remains unclear.
    In the present study, we explored the differential impact of FasL and TNF-     upon apo-
ptosis and inflammation in a renal ischemia-reperfusion injury model using neutralizing 
anti-FasL antibodies and TNF-   receptor 1 (TNFR1)-deficient mice. Our observations indi-
cated that FasL exerts a greater impact on apoptosis and inflammation than TNF-     in mu-
rine ischemic acute kidney injury in vivo.
  Materials  and  Methods 
 Animals 
  Male wild type mice were purchased from Charles River, Japan Inc. (Atsugi, Japan). 
TNF-Rp55 KO mice (TNFR1), generated as previously described   [15]  , had been backcrossed 
onto the BALB/c background for 10 generations, and maintained under specific pathogen-
free housing conditions. No significant differences in growth or weight were found between 
TNFR1 and wild type BALB/c mice. All male animals were used at 6–8 weeks of age. All 
procedures employed in the animal experiments complied with the standards set out in the   
Guidelines for the Care and Use of Laboratory Animals in Takara-machi Campus of Kanaza-
wa University .
  R e a g e n t s  
  FasL (WX1) and anti-FasL neutralizing mAb (FLIM58) were prepared as described pre-
viously   [16–18]  . Mouse TNF-     was purchased from R&D Systems (Minneapolis, Minn., 
USA). FasL (WX1) comprises almost the complete extracellular region of FasL and efficient-
ly kills mature T cells in freshly isolated mouse splenocytes or lymph node cells. Unlike nat-
urally processed mouse soluble FasL, WX1 is biologically active   [17]  .
  Renal  Ischemia-Reperfusion  Model 
 After establishment of general anesthesia with diethyl ether and pentobarbital sodium, 
th e l eft r enal artery an d v ein o f TNFR - 1 -defi ci en t mi ce an d wil d type co n tro ls w er e
exposed by flank incision and clamped for 60 min. Kidneys that did not completely re-
cover after unclamping, as assessed by restoration of normal color, were not included in 
the analysis. After releasing the clamp, the flank incision was closed in two layers with silk 
sutures. The animals received warm saline instilled into the peritoneal cavity during the 29
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procedure and were allowed to recover with free access to food and water. Sham surgery 
was performed in a similar manner, except the renal vessel clamp. A blocking study was 
performed in the same way as described previously   [16]  . Anti-FasL Ab or normal hamster 
IgG (5 mg/ml, 0.1 ml) was injected into the abdominal cavity 1 h before the occlusion of 
renal vessels.
  Immunohistochemistry 
  One portion of the renal tissue was fixed in 10% buffered formalin, then embedded in 
paraffin, sectioned and stained with periodic acid-Schiff (PAS) reagent. The degree of tubu-
lar necrosis was quantified according to a semiquantitative scoring scale: 0, normal kidney; 
1, minimal necrosis ( ! 5%); 2, mild necrosis (5–25%); 3, moderate necrosis (25–75%); 4, severe 
necrosis ( 1  75%)   [19]  . Interstitial infiltrating cells were counted in 20 randomly selected high 
power fields (  !  400) of outer medulla.
    Deparaffinized sections were treated with proteinase K (DAKO, Glostrup, Denmark) 
prior to immunostaining for F4/80, Fas and FasL. Endogenous peroxidase activity and non-
specific binding was blocked by Peroxidase-Blocking Reagent (DAKO), Biotin-Blocking Sys-
tem (DAKO) and Protein Block, Serum-Free (DAKO). Rat anti-mouse F4/80 monoclonal 
antibody (clone: BM8; eBioscience, San Diego, Calif., USA) and hamster anti-mouse Fas and 
FasL antibody (Pharmingen, Franklin Lakes, N.J., USA) were used to detect F4/80, Fas and 
FasL, respectively. Normal rat or hamster IgG were used as a negative control. Rat anti-F4/80 
antibody or hamster anti-mouse Fas and FasL antibody were detected by biotinylated poly-
clonal anti-rat (DAKO) or anti-hamster (Pharmingen) antibodies and the LSAB+ system 
(peroxidase) (DAKO). After washing with PBS containing 0.01% Tween, sections were stained 
with 3,3  -diaminobenzidine (DAB) solution and counterstained with hematoxylin. TdT-me-
diated dUTP nick end labeling (TUNEL)-positive cells were detected by a modified TACS 
TdT DAB kit (R&D Systems). After washing with PBS containing 0.01% Tween, positive cells 
were visualized by alkaline phosphatase and its substrate. Neutrophils were stained using 
alkaline phosphatase substrates kit II (SK-5200) as previously reported  [20] . Infiltrating neu-
trophils and F4/80-positive and TUNEL-positive apoptotic cells were quantified in the out-
er medulla of the injured kidney and the data were expressed as cell number/high power 
fields (400  !   magnification).
    Proximal Tubular Cell Culture 
  Immortalized murine proximal tubular cells   [21]   were cultured in DMEM containing 
10% heat-inactivated FBS, 100 U/ml penicillin and 100     g/ml streptomycin. Cells (2   !   10 6 /
well) were incubated in a 12-well tissue culture plate for 24 h and then made quiescent by 
incubation with 0.1% FBS in DMEM for 24 h. FasL (0–500 U/ml) and TNF-    (0–500 ng/ml) 
were added to the medium and cells were incubated for 6, 24, 48, or 96 h at 37    °    C. After the 
incubation, the percentage of dead cells and chemokine expression was evaluated. Cells were 
incubated in 1 ml of PBS containing 50 l/ml of propidium iodide (Sigma, St. Louis, Mo., USA) 
on ice for 10 min. The dead cells were measured by a FACScan with CellQuest software (BD 
Biosciences, San Jose, Calif., USA).
  Cytokine  Quantification   
 Total RNA was extracted from the kidney and cells were cultured using the RNAqueous 
kit (Ambion Inc., Austin, Tex., USA). RNA was treated with deoxyribonuclease and purified 
with DNA-  free   (Ambion, Inc.). The RNA was quantified by absorbance at 260 nm in a spec-
trophotometer. cDNA was reverse-transcribed from 1   g of total RNA using a RETROscript 
kit (Ambion, Inc.). TNF-     mRNA was detected by 33 cycles of polymerase chain reaction 
(PCR). PCR was found to be linear between 20 and 35 cycles. The following primers were 30
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used for TNF-    : forward: TCTCATCAGTTCTATGGCCC, and reverse: GGGAGTAGA-
CAAGGTACAAC. The mRNA expression of cytokines, chemokines, and the housekeeping 
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was analyzed using an MPCR 
kit (Maxim Biotech, Inc., San Francisco, Calif., USA) according to the manufacturer’s pro-
tocol. Images of UV-illuminated agarose gels were captured, and the density of cDNA bands 
was analyzed using NIH Image software. PCR was found to be linear between 24 and 36 
cycles, and 33 cycles were chosen for all results shown. Cytokine as well as chemokine mRNA 
levels were standardized by GAPDH signals and are expressed relative to the levels found in 
sham-operated mice. 
    Cytokine levels in cell culture supernatants were quantified using a Procarta Cytokine 
Profiling kit (Affymetrix, Santa Clara, Calif., USA), which uses xMAP technology (multi-
analyte profiling Luminex technology) to enable the detection and quantification of multiple 
protein targets simultaneously. Fluorescently encoded antibody beads were detected unique-
ly in a flow cytometer and five mouse cytokines [keratinocyte chemoattractant (KC), MCP-
1, MIP-1    , IL-1, IP-10] were evaluated.
  Statistical  Analysis 
  The mean and standard error of mean (SEM) were calculated on all the parameters de-
termined in this study. Statistical analyses were performed using unpaired Student’s t test, 
Kruskal-Wallis test and ANOVA test. p   !   0.05 was accepted as statistically significant.
  R e s u l t s  
 TNF-   , Fas and FasL Were Expressed in the Kidney after Ischemia-Reperfusion Injury 
 TNF-    mRNA expression was faintly detected in sham-operated kidneys from wild 
type mice but significantly upregulated following ischemia-reperfusion injury (  fig. 1  a). Sim-
ilarly, the expression of Fas protein was also faint in sham-operated kidneys from wild type 
mice but was significantly upregulated after ischemia-reperfusion injury [  fig. 1  b(i, ii), c(i)]. 
Fas protein was mainly detected on tubular epithelial cells. In contrast to Fas, FasL expres-
sion was detected on epithelial cells in sham-operated kidneys from wild type mice. After 
ischemia, infiltrating cells were also positive for FasL [  fig. 1  b(iii, iv), c(ii)]. The number of 
Fas- and FasL-positive cells increased after ischemic kidney injury.
  T N F -     and FasL Participated in Tissue Destruction after Ischemia-Reperfusion Injury 
  Interstitial cell infiltration and tubular necrosis are characteristic pathologic changes 
in renal ischemia-reperfusion injury. Tubular necrosis was evident after ischemic injury 
and peaked at 48 h. TNFR1 deficiency had a minor effect on tubular necrosis. In contrast, 
treatment with anti-FasL Ab significantly prevented tubular necrosis [ fig. 2 a, c(i)]. Further-
more, treatment with anti-FasL Ab significantly reduced cytokine/chemokine expres-
sion and interstitial cell infiltration, especially neutrophil infiltration [  fig. 2  b, c(ii, iii)]. 
F4/80-positive macrophage infiltration was not affected by anti-FasL Ab administration 
[  fig. 2  c(iv)]. In contrast to the effect of anti-FasL Ab, TNFR1 deficiency did not show major 
effects on cytokine/chemokine expression or interstitial cell infiltration after ischemia 
[ fig. 2 b,  c(i–iv)].
  T N F -    , Fas and FasL Participated in Apoptosis after Ischemia-Reperfusion Injury 
  The number of apoptotic TUNEL-positive cells significantly increased following isch-
emia (  fig. 3  a, b). The number of apoptotic cells was significantly diminished in TNFR1-de-
ficient mice and anti-FasL Ab-treated mice with the anti-apoptotic effect being more evident 31
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in anti-FasL Ab-treated mice. In addition, the combination of TNFR1 deficiency and anti-
FasL Ab treatment was not more protective than anti-FasL Ab treatment alone. These results 
were confirmed by the immunohistochemical staining of caspase 3 (  fig. 3  c, d). The number 
of caspase 3-positive cells significantly increased after ischemia and was reduced in TNFR1-
deficient mice and anti-FasL Ab-treated mice. Similar to TUNEL-positive cells, the deficien-
cy of TNFR1 did not further reduce the number of caspase 3-positive cells in the injured 
kidney in mice that also received anti-FasL Ab treatment.
  Fig. 1.   TNF-    and FasL were upregulated in the ischemic injured kidney.   a   TNF-    mRNA and protein 
expression in the injured kidney were detected by RT-PCR and ELISA, respectively, at the indicated time 
points after ischemia-reperfusion injury.   b   Fas (i, ii, iii) and FasL (v, vi, vii) protein were detected by im-
munohistochemical staining on control, sham and injured kidney 24 h after reperfusion, respectively. 
Panels iv and viii indicate control IgG staining for Fas and FasL, respectively.   c   Quantification of Fas- (i) 
and FasL- (ii) positive cells in tissue sections was undertaken in sham-operated and wild type mice. Values 
are mean   8   SEM. Five animals were evaluated for each condition. Original magnification of all images 
is 400  ! .   *  p   !   0.05 compared with sham-operated wild type mice. 32
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  T N F -     and FasL Induced Apoptosis and Cytokine/Chemokine Expression 
 TNF-    induced limited apoptosis on cultured tubular epithelial cells whilst FasL in-
duced significant apoptosis in a dose-dependent manner at 24 h with the pro-apoptotic effect 
continuing until 48 h (  fig. 4  ). Unstimulated cultured tubular epithelial cells produced mini-
mal cytokines and chemokines. However, the protein and mRNA expression of cytokines 
and chemokines significantly increased following FasL stimulation. The protein expression 
of KC peaked at 6 h whilst MIP-1     and IL-1 peaked at 24 h. MCP-1 and IP-10 retained high 
protein expression levels throughout the experimental period. TNF-     weakly upregulated 
cytokine and chemokine expression at all time points examined (  fig. 5  ).
  Fig. 2.   Anti-FasL antibodies and TNFR1 deficiency reduced tubular necrosis and interstitial cell infiltra-
tion after ischemic kidney injury.  a  Histopathologic analysis. PAS-stained outer medulla of the left injured 
kidney is shown for wild type (i, ii, iii) and TNFR1-deficient (iv, v) mice with anti-FasL Ab treatment (ii, 
v) or control IgG treatment (i, iv) 48 h after ischemia reperfusion or sham operation (iii).   b   Cytokine and 
chemokine expression of injured kidney 48 h after reperfusion was detected by RT-PCR.   c  Quantification 
of the ATN score (i) and the numbers of interstitial infiltrating cells (ii), granulocytes (iii) and F4/80-
positive cells (iv) following ischemia. TNFR1+ = Wild type mice; TNFR1– = TNFR1-deficient mice;
FasL+ = anti-FasL Ab-treated mice; FasL– = control IgG-treated mice. Values are means   8   SEM. Five 
animals were evaluated for each condition. Original magnification of all images is 400  ! .   *  p   !   0.05 com-
pared with control IgG-treated wild type mice;   #  p   !   0.05 compared with TNFR1-deficient mice. 33
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  Discussion 
 Apoptosis and inflammation play a key role in the pathogenesis of ischemic acute kidney 
injury. Although the FasL/Fas and TNF-    /TNFR are two fundamental pathways involved 
in many pathological conditions, their differential effect on apoptosis and inflammation in 
acute kidney injury has not been investigated in vivo models thus far. Our study indicated 
that neutralizing anti-FasL Ab treatment diminished inflammatory cell infiltration, tubular 
necrosis and apoptosis more markedly than TNFR1 deficiency. These findings were con-
firmed in cultured tubular epithelial cells and these data emphasize the important impact of 
the FasL/Fas system on ischemic kidney injury.
    Neutralizing anti-FasL Ab treatment resulted in more significant anti-inflammatory ef-
fects     than TNFR1 deficiency, including a more marked reduction in inflammatory cell in-
filtration, chemokine production and tubular necrosis in vivo. One explanation for these 
findings would be the extensive upregulation of Fas and FasL expression on tubular epithe-
lial cells after reperfusion. FasL mRNA and protein expression were reported to be increased 
following ischemia  [22]  with cytokines such as TNF-  , IL-1   and -   acting to upregulate cell 
surface Fas in renal cells   [23]  . The increased Fas and FasL expression exacerbated the sever-
ity of ischemic kidney injury  [11, 24] . Furthermore, tubular epithelial cells co-express Fas and 
  Fig. 3.   Anti-FasL antibody treatment and TNFR1 deficiency reduced apoptosis after ischemic kidney in-
jury. Kidney sections obtained 24 h following ischemia were stained for TUNEL and caspase 3.   a ,    c   Rep-
resentative results for kidneys from indicated mice (400 !  magnification).  b ,    d  Quantification of the num-
ber of TUNEL-positive and caspase 3-positive cells. Values are means  8  SEM. TNFR1+ = Wild type mice; 
TNFR1– = TNFR1-deficient mice; FasL+ = anti-FasL Ab-treated mice; FasL– = control IgG-treated mice. 
  *  p   !   0.05 compared with control IgG-treated wild type mice;   #  p   !   0.05 compared with TNFR1-deficient 
mice. 34
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FasL with the expression level of Fas on tubular epithelial cells increased by cytokine treat-
ment   [25]  . This local amplification system underlies the marked impact of the FasL/Fas sys-
tem on inflammation. In contrast, mice with disrupted FasL/Fas systems are protected from 
tubular cell injury after ischemia reperfusion   [11]  . Thus, the effect of ischemia-reperfusion 
injury upon the FasL/Fas system acts to augment tissue destruction.
    There are alternative explanations for the dominance of the FasL/Fas system over the 
TNF-   /TNFR system. FasL is able to induce NF-  B activation and IL-8 production by a Fas-
associated death domain protein (FADD)-dependent mechanism, which is distinctively reg-
ulated by TNF-       [2, 26]  . The production of IL-8 and other cytokines have been reported to 
participate in inflammatory reactions in the diseased kidney   [20, 27–29]   and this may part-
ly explain the difference between the FasL/Fas and TNF-    /TNFR1 pathways in vivo.
    Our data demonstrated that FasL antibody diminished the number of apoptotic cells 
more than TNFR1 deficiency. FasL and TNF-     bind to Fas and TNFR1 with the apoptotic 
signal mediated by death domain-containing cytoplasmic proteins such as FADD and
TNFR1-associated death domain protein (TRADD)  [30, 31] . Both signaling cascades are ini-
tiated by different death domains and end in common activation of caspase 8. Although 
  Fig. 4.  Stimulation with FasL and TNF-   induced apoptosis of cultured tubular epithelial cells. Apo ptotic 
cells were detected as a sub G1 population by FACS analysis following propidium iodide staining. Repre-
sentative data of unstimulated cells (  a  i) and combined stimulation with FasL (500 U/ml) and TNF-    (500 
ng/ml) (  a  ii). Quantification of the levels of apoptosis is shown in   b   following stimulation of cultured cells 
for 24 h with FasL and/or TNF-     at the indicated concentrations. Values are mean   8   SEM.   *  p   !   0.05 
compared with unstimulated control cells. 35
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these two pathways seem similar, Fas-mediated cell death occurs much more rapidly than 
that triggered by TNFR1   [32]  . In accordance with this work, we demonstrated that Fas-me-
diated apoptosis was dominant over TNFR1-mediated apoptosis in our model of renal isch-
emia-reperfusion injury. These findings were confirmed by our in vitro study. Further stud-
ies will be needed to reveal the precise molecular mechanisms of these differences between 
the Fas and TNFR1 pathway.
    Although apoptosis and necrosis are well-characterized findings in ischemia-reperfu-
sion injury, several alternative caspase-independent cell death pathways have been described 
 [33] . For example, oncosis describes cell death that is characterized by cell swelling, organelle 
swelling, membrane blebbing and increased membrane permeability and may occur when 
ATP generation is attenuated or when cellular energy consumption becomes dysregulated 
  [34]  . These conditions are present in ischemia-reperfusion injury. Moreover, it was reported 
that oncosis is partially induced by Fas   [35]   and it might be reasonable to speculate that Fas 
participates in the pathogenesis of renal ischemia-reperfusion injury via the induction of on-
cosis. 
  Fig. 5.   Cytokine and chemokine expression by cultured tubular epithelial cells was increased following 
stimulation with FasL and/or TNF-  . Cytokine/chemokine expression of cultured tubular epithelial cells 
was determined using a Procarta Cytokine Profiling kit and multiplex PCR.   a   Quantification of cyto-
kines/chemokines was performed at the indicated time points. Representative data are shown in   b   for the 
indicated stimulation conditions.   c   Quantification of density of each band was normalized relative to 
GAPDH. The cultured cells were stimulated with FasL and/or TNF-     at the indicated concentrations for 
24 h. Values are mean   8   SEM.   *  p   !   0.05 compared with unstimulated control cells. 36
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